Please try another search
Cosmos Health Inc., formerly Cosmos Holdings Inc., is a pharmaceutical company. The Company is engaged in providing nutraceuticals and distributors of pharmaceuticals, branded generics, over-the-counter (OTC) medications, and medical devices. The Company is engaged in the nutraceuticals sector through its own proprietary lines of products Sky Premium Life and Mediterranation. The Company is engaged in the pharmaceutical sector through the provision of a broad line of branded generics and OTC medications and is involved in the healthcare distribution sector through its subsidiaries in Greece and the United Kingdom serving retail pharmacies and wholesale distributors. It is also focused on the research and development (R&D) of novel patented nutraceuticals (IP) and root extracts as well as on the R&D of complex generics and OTC products. It has developed a global distribution platform. It has distribution centers in Thessaloniki and Athens, Greece and Harlow, United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Grigorios Siokas | 57 | 2016 | Chairman & CEO |
Athanasios Kolefas | - | 2019 | Member of Advisory Board |
John J. Hoidas | 57 | 2016 | Independent Director |
Orestes Varvitsiotes | - | 2017 | Member of Advisory Board |
Alexios Papaconstantinou | - | 2021 | Member of Advisory Board |
Anastasios Tzikas | - | 2018 | Member of Advisory Board |
Anastasios Aslidis | 63 | 2022 | Independent Director |
Panagiotis Zoumpoulakis | - | 2022 | Member of Advisory Board |
Manfred Ziegler | - | 2022 | Independent Director & Member of Advisory Board |
Suhel Bhutawala | 44 | 2023 | Director |
Demetrios G. Demetriades | 57 | 2014 | Secretary & Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review